Dear Editor,
With widespread PSA screening, the number of equivocal cases of prostate cancer has dramatically increased. This has led to a concomitant increase in the number of prostate biopsies, many of which might be deemed unnecessary. Prostate biopsy is an invasive procedure, fraught with potential complications. A non-invasive alternative would certainly be preferable.
Dr. Eric SchiVer has reviewed the many prostate cancer biomarkers and their impact on the clinical management of this disease [1] . These biomarkers utilize blood, tissue, urine, and seminal Xuid assays. He posits that both urine and seminal Xuid may detect early prostate malignancy through exfoliated cancer cells and secreted prostate products. Urine may also be a potential source of prostate-speciWc markers. However, since a signiWcant volume of seminal Xuid is produced by the prostate and seminal vesicles, seminal Xuid might be an even better choice for this purpose. Cytological examination of the seminal Xuid may be able to provide a more direct method of revealing an underlying prostate and/or seminal vesicle malignancy and serve as an alternative to prostate biopsy.
DiVerentiating prostate from other epithelial cells could present a problem for the cytologist. However, some investigators have reported having done so using special staining techniques [2, 3] . The use of semen cytology could not only evolve into a feasible method for identifying the tumor cells but also be able to ascertain the grade of the underlying tumor.
In order to establish the validity of using semen cytology as a method for diagnosing prostate carcinoma, one must Wrst Wnd answers to the following questions: There is a real need for a less invasive diagnostic procedure than prostate biopsy. Furthermore, if prostate malignancy is found, it is important to diVerentiate between the men with aggressive tumors from those with slow growing tumors which may present no clinical problems.
I am hoping that these comments will stimulate a more thorough study to ascertain if semen cytology can be used as an alternative for prostate biopsy. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
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